Yield10 Bioscience Stock - Wednesday operations and strategy snapshot
Published on 06/17/2026 at 15:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 15:56 CET. Details in the imprint.
Yield10 Bioscience (US98585L1035) is a US agricultural biotechnology company focused on developing gene-edited oilseed crops for specialty oils and sustainable materials. With no new regulatory filings or market-moving releases today, the focus shifts to its operating model and strategy.
Background and price data on Yield10 Bioscience stock
All news, filings and price data for Yield10 Bioscience stock are collected on the ad hoc news topic page and the company’s own investor-relations site.
What recent filings show
Yield10 Bioscience last filed its annual report on Form 10-K for 2023 with the US Securities and Exchange Commission, detailing its financial position, risks and research programs. The SEC 10-K filing outlines revenue, losses and cash runway.
According to that document, the company generated only modest collaboration revenue and reported a net loss for 2023, reflecting its development-stage status. Management highlighted the need for additional capital over time to fund operations and commercial-scale planting.
Operations and strategy on Wednesday
Yield10 Bioscience positions itself as a technology platform company using gene-editing and trait-discovery tools to improve oilseed crops such as camelina. Its strategy emphasizes higher-value specialty oils and feedstocks for biofuels, bioplastics and other industrial uses.
The 2023 10-K explains that Yield10 is prioritizing field trials, seed scale-up and regulatory progress for genetically engineered camelina lines, while pursuing potential partnerships with larger seed or energy companies. In the company’s full-year 2023 update, management described camelina as a key commercial opportunity.
What the company sells
Yield10 Bioscience does not yet have a broad commercial product portfolio comparable to large agribusiness peers. Its core development work focuses on engineered camelina seed traits intended to produce specialty oils for food, feed and bio-based industrial applications once regulatory and commercial milestones are met.
Where the stock trades today
The shares of Yield10 Bioscience (US98585L1035) trade on Nasdaq at $0.72 as of 06/17/2026, 15:56 CET.
Key facts on Yield10 Bioscience stock
- Company: Yield10 Bioscience, Inc.
- ISIN: US98585L1035
- WKN: A2AS9R
- Ticker: YTEN
- Venue: Nasdaq
- Price (as of 06/17/2026, 15:56 CET): 0.72 USD
- Market cap: 12,500,000 USD (as of 06/17/2026)
- Sector / Industry: Materials - Agricultural Chemicals / Agricultural Biotechnology
- Index membership: not a member of major headline indices such as the S&P 500 or Nasdaq-100
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
